Bloomberg Markets The Close Romaine Bostick breaks down the day's top stories and trading action leading into the close.
Bloomberg Businessweek Insight and analysis of top stories from our award winning magazine "Bloomberg Businessweek". Listen
Bloomberg Businessweek Highlights from a week-long virtual event bringing Bloomberg Businessweek magazine to life. Carol Massar and Tim Stenovec host a look back at the best interviews, discussions and more.
CityLab ‘Bounty Hunters’ Are Earning Money for Voter Signatures in California. Now, There’s a Backlash
Subscriber OnlyPoliticsPrognosisEU, Sanofi Talks on Covid-19 Vaccine Aim for Supply Next YearDeal would be for 300 million doses in second half of 2021Talks are part of broad EU outreach campaign to drug companiesPhotographer: Anthony Kwan/BloombergByJonathan Stearns+FollowJuly 17, 2020, 2:21 PM UTCSign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.European Union negotiations with Sanofi to secure a coronavirus vaccine aim for 300 million doses in the second half of 2021, according to a person familiar with the situation.
